Přihlásit se Zaregistrujte se zdarma

% krátkých akcií společnosti Inhibrx

Jaká je hodnota metriky % krátkých akcií společnosti Inhibrx?

Hodnota metriky % krátkých akcií společnosti Inhibrx, Inc. je 15.63%

Jaká je definice metriky % krátkých akcií?



% krátkých akcií (Short% of float) je počet akcií prodaných na krátko v porovnání se všemi akciemi v oběhu (float) vyjádřený v procentech.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

% krátkých akcií společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Inhibrx

Čemu se věnuje společnost Inhibrx?

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

Firmy s metrikou % krátkých akcií podobnou společnosti Inhibrx